Abstract
Prostate Carcinoma: this chapter outlines the incidence, risk factors, clinical presentation, investigations, treatments and prognosis of cancer at this anatomical site. These features are correlated with the core data that are required to make the corresponding histopathology reports of a consistently high quality, available in an appropriate timeframe, and clinically relevant to patient management and prognosis. Summary details of the common cancers given at this site include: gross description, histological types, tumour grade/differentiation, extent of local tumour spread, lymphovascular invasion, lymph node involvement, and the status of excision margins. Current WHO Classifications of Malignant Tumours and TNM7 are referenced. Notes are provided on other associated pathology, contemporary use of immunohistochemistry, updates on the role of evolving molecular tests, and the use of these ancillary techniques as biomarkers in diagnosis, and prediction of prognosis and treatment response. A summary is given of the commoner non-carcinoma malignancies that are encountered at this site in diagnostic practice.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Bibliography
Ali TZ, Epstein JI. Perineural involvement by benign prostatic glands on needle biopsy. Am J Surg Pathol. 2005;29:1159–63.
Allen DC. Histopathology reporting: guidelines for surgical cancer. 2nd ed. London: Springer; 2006.
Association of Directors of Anatomic and Surgical Pathology. Recommendations for the reporting of prostate carcinoma. Am J Clin Pathol. 2008;129:24–30.
Bennett VS, Varma M, Bailey DM. Guidelines for the macroscopic processing of radical prostatectomy and pelvic lymphadenectomy specimens. J Clin Pathol. 2008;61:713–21.
Berney DM, Fisher G, Kattan MW, Oliver RTD, Moller H, Fearn P, Eastham J, Scardino P, Cuzick J, Reuter VE, Foster CS for the Trans-Atlantic prostate group. Pitfalls in the diagnosis of prostate cancer: retrospective review of 1791 cases with clinical outcome. Histopathology. 2007;51:452–7.
Bostwick DG, Cheng L. Urologic surgical pathology. 2nd ed. Philadelphia: Mosby/Elsevier; 2008.
Bostwick DG, Cheng L. Precursors of prostate cancer. Histopathology. 2012;60:4–27.
Cheng L, Montironi R, Bostwick DG, Lopez-Beltran A, Berney DM. Staging of prostate cancer. Histopathology. 2012;60:87–117.
Delahunt B, Miller RJ, Srigley JR, Evans AJ, Samaratunga H. Gleason grading: past, present and future. Histopathology. 2012;60:75–86.
Deng F-M, Mendrinos SE, Das K, Melamed J. Periprostatic lymph node metastasis in prostate cancer and its clinical significance. Histopathology. 2012;60:1004–8.
Doud N, Li G, Evans AJ, van der Kwast TH. The value of triple antibody (34βE12 + p63 + AMACR) cocktail stain in radical prostatectomy specimens with crushed surgical margins. J Clin Pathol. 2012;65:437–40.
Eble JN, Sauter G, Epstein JI, Sesterhenn IA. WHO classification of tumours. Pathology and genetics. Tumours of the urinary system and male genital organs. Lyon: IARC Press; 2004.
Egevad L, Algaba F, Berney DM, Boccon-Gibod L, Griffiths DF, Lopez-Beltran A, Mikuz G, Varma M, Montironi R. Handling and reporting of radical prostatectomy specimens in Europe: a web-based survey by the European Network of Uropathology (ENUP). Histopathology. 2008;53:333–9.
Egevad L, Ahmad AS, Algaba F, Berney DM, Boccon-Gibod L, Comperat E, Evans AJ, Griffiths D, Grobholz R, Kristiansen G, Langer C, Lopez-Beltran A, Montironi R, Moss S, Oliveira P, Vainer B, Varma M, Camparo P. Standardization of Gleason grading among 337 European pathologists. Histopathology. 2013;62:247–56.
Epstein JI. Diagnosis of limited adenocarcinoma of the prostate. Histopathology. 2012;60:28–40.
Epstein JI, Allsbrook WC, Amin MB, Egevad LL and the ISUP Grading Committee. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol. 2005;29:1228–42.
Epstein JI, Srigley J, Grignon D, Humphrey P. Recommendations for the reporting of prostate carcinoma. Hum Pathol. 2007;38:1305–9.
Evans AJ. α - Methylacyl Co A racemase (P504S): overview and potential in diagnostic pathology as applied to prostate needle biopsies. J Clin Pathol. 2003;56:892–7.
Gleason D. Histologic grading and clinical staging of prostatic carcinoma. In: Tannenbaum M, editor. Urologic pathology. The prostate. Philadelphia: Lea and Febiger; 1977. p. 171–98.
Gleason DF. Histologic grading of prostate cancer; a perspective. Hum Pathol. 1992;23:273–9.
Herawi M, Epstein JI. Specialized stromal tumors of the prostate: a clinicopathologic study of 50 cases. Am J Surg Pathol. 2006;30:694–704.
Humphrey PA. Diagnosis of adenocarcinoma in prostate needle core biopsy tissue. J Clin Pathol. 2007;60:35–42.
Humphrey PA. Histological variants of prostatic carcinoma and their significance. Histopathology. 2012;60:59–74.
Kench JG, Delahunt B, Griffiths DF, Humphrey PA, McGowan T, Trpkov K, Varma M, Wheeler TM, Srigley JR. Dataset for reporting of prostate carcinoma in radical prostatectomy specimens: recommendations from the International Collaboration on Cancer Reporting. Histopathology. 2013;62:203–18.
Kristiansen G. Diagnostic and prognostic molecular biomarkers for prostate cancer. Histopathology. 2012;60:125–41.
Lopez JI, Etxezarraga C. The combination of millimetres of cancer and Gleason index in core biopsy is a predictor of extraprostatic disease. Histopathology. 2006;48:663–7.
Marks RA, Lin H, Koch MO, Cheng L. Positive-block ratio in radical prostatectomy specimens is an independent predictor of prostate-specific antigen recurrence. Am J Surg Pathol. 2007;31:877–81.
McNeal JE. Normal histology of the prostate. Am J Surg Pathol. 1998;12:619–33.
Montironi R, Mazzucchelli R, Algaba F, Lopez-Beltram A. Morphologic identification of the patterns of prostatic intraepithelial neoplasia and their importance. J Clin Pathol. 2000;53:655–65.
Montironi R, Scarpelli M, Mazzucchelli R, Cheng L, Lopez-Beltran A. The spectrum of morphology in non-neoplastic prostate including cancer mimics. Histopathology. 2012;60:41–58.
Oliai BR, Kahane H, Epstein JI. A clinicopathologic analysis of urothelial carcinomas diagnosed on prostate needle biopsy. Am J Surg Pathol. 2001;25:794–801.
Osunkoya A, Netto GJ, Epstein JI. Colorectal adenocarcinoma involving the prostate: report of 9 cases. Hum Pathol. 2007;38:1836–41.
Paner GP, Aron M, Hansel DE, Amin AB. Non-epithelial neoplasms of the prostate. Histopathology. 2012;60:166–86.
Pickup M, van der Kwast TH. My approach to intraductal lesions of the prostate gland. J Clin Pathol. 2007;60:856–65.
Ryan P, Finelli A, Lawrentschuk N, Fleshner N, Sweet J, Cheung C, van der Kwast T, Evans A. Prostatic needle biopsies following primary high intensity focused ultrasound (HIFU) therapy for prostatic adenocarcinoma: histopathological features in tumour and non-tumour tissue. J Clin Pathol. 2012;65:729–34.
Schowinsky JT, Epstein JI. Distorted rectal tissue on prostate needle biopsy. A mimicker of prostate cancer. Am J Surg Pathol. 2006;30:866–70.
Srigley JR, et al. Protocol for the examination of specimens from patients with carcinoma of the prostate gland. Arch Pathol Lab Med. 2009;133:1568–76.
Srigley JR, Delahunt B, Evans AJ. Therapy-associated effects in the prostate gland. Histopathology. 2012;60:153–65.
Sung M-T, Davidson DD, Montironi R, Lopez-Beltran A, Cheng L. Radical prostatectomy specimen processing: a critical appraisal of sampling methods. Curr Diagn Pathol. 2007;13:490–8.
The Royal College of Pathologists. Cancer Datasets (Adult Renal Parenchymal Cancer, Renal Tumours in Childhood, Penile Cancer, Prostatic Carcinoma, Testicular Tumours and Post-Chemotherapy Residual Masses, Tumours of the Urinary Collecting System) and Tissue Pathways (Medical Renal Biopsies, Urological Pathology). Accessed at http://www.rcpath.org/index.asp?PageID=254.
Vainer B, Toft BG, Olsen KE, Jacobsen GK, Marcussen N. Handling of radical prostatectomy specimens: total or partial embedding? Histopathology. 2011;58:211–6.
Van der Kwast TH, Lopes C, Santonja C, Pihl C-G, Neetens I, Martikainen P, Di Lollo S, Bubendolf L, Hoedemaeker RF. Members of the pathology committee of the European Randomised Study of Screening for Prostate Cancer (ERSPC). Guidelines for processing and reporting of prostatic needle biopsies. J Clin Pathol. 2003;56:336–40.
Van Oort IM, Bruins HM, Kiemeney LA, Knipscheer BC, Witjes JA, Hulsbergen-van de Kaa CA. The length of positive surgical margins correlates with biochemical recurrence after radical prostatectomy. Histopathology. 2010;56:464–71.
Vargas SO, Jiroutek M, Welch WR, Nucci MR, D’Amico AV, Renshaw AA. Perineural invasion in prostate needle biopsy specimens. Correlation with extraprostatic extension at resection. Am J Clin Pathol. 1999;111:223–8.
Varma M, Jasani S. Diagnostic utility of immunohistochemistry in morphologically difficult prostate cancer: review of current literature. Histopathology. 2005;47:1–16.
Varma M, Morgan M, Amin MB, Wozniak S, Jasani B. High molecular weight cytokeratin antibody (clone 34βE12): a sensitive marker for differentiation of high-grade invasive urothelial carcinoma from prostate cancer. Histopathology. 2003;42:167–72.
Wittekind CF, Greene FL, Hutter RVP, Klimpfinger M, Sobib LH. TNM atlas: illustrated guide to the TNM/pTNM classification of malignant tumours. 5th ed. Berlin: Springer; 2005.
Wolters TK, van der Kwast TH, Vissers CJ, Bangma CH, Roobol M, Schroder FH, van Leenders GJ. False-negative prostate needle biopsies: frequency, histopathologic features, and follow-up. Am J Surg Pathol. 2010;34:35–43.
Yao JL, Huang J, di Sant’Agnese PA. Small cell carcinoma of the prostate. Diagn Histopathol. 2008;14:117–21.
Young RH, Srigley JR, Amin MB, Ulbright TM, Cubilla A. Tumors of the prostate gland, seminal vesicle, male urethra and penis. Altas of tumour pathology. Series 3. Fascicle 28. Washington DC: AFIP; 2000.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Allen, D.C. (2013). Prostate Carcinoma. In: Histopathology Reporting. Springer, London. https://doi.org/10.1007/978-1-4471-5263-7_31
Download citation
DOI: https://doi.org/10.1007/978-1-4471-5263-7_31
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-5262-0
Online ISBN: 978-1-4471-5263-7
eBook Packages: MedicineMedicine (R0)